Impact BioMedical, Inc. (IBO)
4.68
-0.16
(-3.31%)
USD |
NYAM |
Oct 06, 16:00
4.62
-0.06
(-1.28%)
After-Hours: 20:00
Impact BioMedical Price : 4.68 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 5.00 | 5.05 | 4.43 | 4.68 | 21172.00 |
| Oct 05, 2026 | 5.16 | 5.42 | 4.84 | 4.84 | 17339.00 |
| Oct 02, 2026 | 5.54 | 5.54 | 5.265 | 5.320 | 11554.00 |
| Oct 01, 2026 | 5.88 | 5.88 | 5.43 | 5.43 | 8991.00 |
| Sep 30, 2026 | 5.48 | 5.75 | 5.48 | 5.60 | 3927.00 |
| Sep 29, 2026 | 5.50 | 6.17 | 5.43 | 5.60 | 9044.00 |
| Sep 28, 2026 | 5.69 | 6.023 | 5.590 | 5.61 | 9266.00 |
| Sep 25, 2026 | 5.80 | 6.500 | 5.58 | 5.69 | 20646.00 |
| Sep 24, 2026 | 6.86 | 6.86 | 5.51 | 5.65 | 23370.00 |
| Sep 23, 2026 | 6.46 | 7.11 | 5.62 | 6.63 | 40516.00 |
| Sep 22, 2026 | 7.002 | 7.002 | 6.658 | 6.658 | 12266.00 |
| Sep 21, 2026 | 7.446 | 7.532 | 6.942 | 7.013 | 7219.00 |
| Sep 18, 2026 | 7.211 | 7.446 | 6.942 | 7.446 | 7737.00 |
| Sep 17, 2026 | 6.585 | 7.698 | 6.585 | 7.211 | 20246.00 |
| Sep 16, 2026 | 6.815 | 6.903 | 6.285 | 6.285 | 13050.00 |
| Sep 15, 2026 | 6.058 | 6.927 | 6.039 | 6.676 | 9647.00 |
| Sep 14, 2026 | 5.706 | 6.536 | 5.706 | 6.109 | 8955.00 |
| Sep 11, 2026 | 5.637 | 6.184 | 5.637 | 5.808 | 24611.00 |
| Sep 10, 2026 | 5.995 | 6.414 | 5.473 | 5.565 | 21590.00 |
| Sep 09, 2026 | 6.424 | 6.436 | 6.080 | 6.231 | 3894.00 |
| Sep 08, 2026 | 6.436 | 6.735 | 6.310 | 6.310 | 11969.00 |
| Sep 04, 2026 | 6.058 | 8.077 | 5.931 | 6.815 | 327551.0 |
| Sep 03, 2026 | 6.058 | 6.171 | 5.933 | 6.058 | 6532.00 |
| Sep 02, 2026 | 5.962 | 6.184 | 5.805 | 6.184 | 3575.00 |
| Sep 01, 2026 | 6.095 | 6.184 | 5.749 | 5.780 | 2114.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| LENZ Therapeutics, Inc. | 3.79 |
| Enveric Biosciences, Inc. | 1.47 |
| ANI Pharmaceuticals, Inc. | 71.52 |
| Corcept Therapeutics, Inc. | 119.57 |
| Veru, Inc. | 2.47 |
Price Related Metrics
| PS Ratio | 880.52 |
| Price to Book Value | 3.714 |
| Earnings Yield | -26.48% |
| Market Cap | 39.98M |